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Abstract:
Objective and Background:  Morton’s neuroma is
essentially a benign tumor in the foot, which may cause
extreme pain and disability.  Both conservative and
surgical modalities have been used, but as yet, neither has
been successful in resolving the condition.  This report
introduces Functional Fascial Taping (FFT) developed by
Alexander, as a new treatment regime and examines its
effectiveness in the management of Morton’s neuroma.
Discussion:  Functional Foot Index (FFI) was used to
assess the effectiveness of this taping modality
demonstrating both amelioration of pain and improvement
in functionality.  Although there is anecdotal evidence to
support the benefits of Functional Facial Taping (FFT) in
the treatment of Morton’s Neuroma, a more detailed study
is warranted using larger numbers of participants to examine
its long and short-term benefits.
Key words:  Morton’s neuroma, taping, disability, pain,
foot.
INTRODUCTION
Morton’s neuroma, while a rare condition, is the most
common cause of neuralgia in the foot not only in athletes,
but also the general public.  It commonly afflicts young
females, resulting in significant pain and disability.
Diagnosing Morton’s neuroma is equivocal, with many
stipulating that a case history is all that is required, whilst
others believe various imaging modalities and cortisone
injections provide the best confirmation for a diagnosis.
Etiology is still a mystery.  Many theories have been
proposed, and treatment modalities have been many and
varied, ranging from conservative therapy to surgery.
Recently, a new taping technique, Functional Fascial
Taping (FFT)ä has been implemented in the treatment of
Morton’s neuroma with outstanding anecdotal results.
This report introduces FFT ä as a new treatment regime
and examines its effectiveness in the management of
Morton’s neuroma.
MORTON’S NEUROMA
Not a true tumor, Morton’s neuroma has been described as
a “perineurofibrosis” of the common digital nerve1-13.  It
commonly effects the second and third interspace,
occasionally the fourth and rarely the first interspace.
Neuromata occur bilaterally in 15% of affected individuals,
but multiple neuromas in one foot are extremely rare14.  It
has been found to be more prevalent in women under 50
years due to the delicate and pliable nature of the
foot4,6,10,14,15.
Histological examination of neuromata revealed perineural
fibroma, which postulated traumatic origin6.  It’s believed
that tethering of the nerve occurs from repetitive pinching
of the plantar nerve between the metatarsal heads during
abnormal movements.  Many authors4,15,16  argue that the
third nerve is more vulnerable to trauma due to its larger
diameter, as well as the relatively smaller spaces between
the metatarsal heads/transverse ligament region in the
second and third web12,17-19.
Force on the nerve may be exaggerated by failure of the
normal function of the first ray (eg. bunion formation), the
presence of pes cavus, or disorders associated with
increased loading of the second or third ray8.  Laxity of the
intermetatarsal ligament allows the interdigital nerve tissue
to rise up between the metatarsal heads where it is subject
to compressive trauma14,16,20.  Other possible causes of
neuromata are flattening of the medial arch, and ischemic
changes within the nerve12,14,17.
The classic symptom of interdigital neuromata is sharp
stabbing, burning, cramping or throbbing pain in the
forefoot, which is relieved by removing the shoe and
massaging the area.  The pain tends to recur on
weightbearing3,8,12,14,21,22.  In the early stages generalised
pain is felt in the forefoot, but normally by the time the
symptoms have been present for 5-6 months, the pain
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becomes localised to a specific interspace.  Paresthesia,
numbness, and hyperesthesia of adjacent toes may be
present, and patients have described a hard pea sensation
or lump when walking14,22.  Some patients describe that
they feel a “click” or “catch” on weightbearing, associated
with acute pain3,14.  The pain is usually intermittent,
dependant on the shoe type.  Most patients will have
greater symptoms in tight shoes, although a few have more
symptoms in wide shoes.
DIAGNOSIS OF MORTON’S NEUROMA
The most useful clinical test for the diagnosis of Morton’s
neuroma is to perform a web space compression test which
produces severe pain by squeezing the metatarsal heads
together with one hand and simultaneously compressing
the involved web space with the thumb and index finger of
the opposite hand.  This can also produce a painful and
palpable click known as Mulder’s sign4,6,9,12,16,23,24, which
may result in the mass being pinched for a moment
between the metatarsal heads causing characteristic pain,
as the tumor escapes into the sole of the foot.  A palpable
click with reproduction of the patient’s symptoms is
considered a positive finding, highly suggestive of a
neuroma9.  Palpation of the involved web space may not
only cause pain locally, but it may also radiate along the
involved digits distally23,25.  A positive Tinel’s sign4,21
upon examination may confirm the diagnosis of neuroma,
but it cannot determine the type of lesion or the tissues
involved.  Diminished sensation to pinprick in the third
and fourth interspace is occasionally found, and less often
there is hyperesthesia in the cleft, however, sensation
often appeared normal, possibly because of the “take
over” from adjacent normal nerves7.  No motor symptoms
are experienced because the nerve affected is sensory.
The diagnosis of interdigital neuroma can usually be made
by careful recollection of case histories and physical
examination, however localization of the neuroma may be
difficult5,13,26,27.  Although Mulder’s sign is trusted clinically,
its accuracy has yet to be reported.  A valid and reliable
method for identifying, localizing and quantifying Morton’s
neuroma is lacking.  Other means of diagnosing neuromata
include cortisone injections and various imaging modalities
(plain radiographs, MRI, CT and ultrasonography).
Cortisone injections are often used as part of physical
examination, to confirm the diagnosis and for therapeutic
treatment of Morton’s neuroma10.  Although expensive,
the best imaging modality is MRI, as it produces excellent
soft-tissue contrast without ionising radiation1,3,5,6,10,13,21,23,26.
However it must be noted that MRI scans are not infallible,
and can produce false negative results22.
Ultrasound examination for soft tissue pathology in the
foot and ankle has become a valuable adjunct to the history
and physical examination6,10,27.  Although ultrasound is a
highly accurate technique in diagnosing the presence,
location, and size of interdigital neuromas, occasionally,
an interspace is so narrow that ultrasound may be
inconclusive.
TREATMENT OF MORTON’S NEUROMA
Morton’s original treatment for this condition was
amputation of the fourth toe and fourth metatarsal16.
Modern treatment of Morton’s neuroma is less radical,
and encompasses both conservative and surgical
approaches.  Conservative treatment comprises low-heeled
wide, comfortable shoes with large toe boxes, metatarsal
bars, and metatarsal pads (adhesive backed felt pads)
placed proximal to the symptomatic interspace.  Arch
supports, custom-made foot orthoses, physical therapy,
NSAIDS and injections of a combined corticosteroid and
local anesthetic into the involved web space are also used2-
4,10,12,14,15,20,22,27-29.
Although surgery, whether it is excision, neurolysis or
release of the intermetatarsal ligament, is often the only
option once conservative treatment has failed, it has many
associated complications.  There have been reports of
post-surgical infection, keloid formation and recurrent
neuromas after initial surgery5,10,14,15,28,30.  Gaynor27
demonstrated that conservative treatment was beneficial
in acute cases which are prevalent in young persons, whilst
surgical management was five times more successful than
conservative treatment in chronic cases involving older
persons.
Recurrent interdigital neuromas appear to develop more
rapidly than primary neuromas, with the recurrent neuroma
being located proximal to the primary neuroma.  Greater
than 30% of the patients have continued paraesthesia and
positive Tinel sign.  Pain from recurrent neuroma may
never go away only change locations2.
FUNCTIONAL FASCIAL TAPING
Unlike conventional taping which is used to limit motion
or support injured sites, functional fascial tapingä is
employed to increase range of motion and decrease/
alleviate pain in parts of the body where fascial
dysfunctions are present.  There are three main types of
fascia: superficial, deep and subserous.  The fascial system
is a vast network of fibrous connective tissue, which
envelops the entire body, and is continuous from region
to region31-34.
Muscular or visceral action of one part may exert tension
or a pull on neighbouring parts through the connective
tissue32,34.  Excessive force, due to strain or repetitive
motion against the restriction barrier, may cause local
inflammation and pain, due to the release of pain-producing
chemical mediators.  Inflammation can result in adhesive
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fibrosis, which leads to the development of an area of
restriction and reduced elasticity (ie. fascial tension)31.
Alexander35-39 demonstrated the use of FFTä for the
treatment of interdigital neuromas among ballet dancers,
with astounding anecdotal results.  Immediately following
application of the tape, the dancers reported no neural
pain.  The author reapplied the tape two days after the
initial consultation, and reassessed the dancers every six
months for three years, finding that they were
asymptomatic.  He argued that by applying the tape in a
functional range of motion, where fascial dysfunction is
prevalent, the contracture and fibrotic process maybe
arrested or reversed.
CLINICAL MEASURES
The Visual Analogue Scale (VAS) is a line 10cm long,
the ends of which are labeled as extremes of pain, from
no pain to the worst pain the participant has ever
experienced.  There is much evidence supporting the
internal validity and reliability of the VAS as a self-
reported measure of pain intensity40-46.  VAS is extremely
sensitive to treatment effects47-50.  There may be some
confusion with patients understanding and using VAS, but
explanation and practice should decrease the risk of error40-
46.
The Foot Function Index (FFI) measures the quality of
life impact of the neuroma in terms of pain, disability and
activity restriction.  FFI consists of 23 items in three sub-
scales: Foot pain, Disability and Activity limitation.  All
items are rated using the VAS.  FFI has good test-retest
properties (r = 0.87) and has been shown to be an excellent
practical means of measuring foot function in an outpatient
setting, over relatively short periods of time (r = 0.96)51.
CASE STUDY
A 36-year-old female, who is a full-time student, was
referred to the clinic by a podiatrist, with a diagnosis of
Morton’s neuroma.  The pain was described as deep dull
ache, which had the propensity to escalate to a sharp,
stabbing pain, in the third interspace of the left foot.  The
patient also experienced intermittent pins and needles
over both dorsal and plantar aspects of the left foot.
The patient reported the pain began insidiously two years
ago, when she was running.  At the time, she sought no
treatment, because the pain spontaneously resolved.  The
pain seemed to recur during summer, when the patient
wore sandals with straps that compressed the forefoot, and
ever since, has been restricted to wearing one type of
footwear.  The pain prevented the patient from carrying
out her usual activities including, walking (especially
without shoes), kneeling down gardening with toes curled
under foot, and wearing various other footwear.  She rated
the pain at its worst, according to the FFI as 79%.  The
patient rated her pain at the time of the first consultation
according to FFI as 5%, as she had been frequenting a
podiatrist for treatment, which included taping and orthotics
with a metatarsal bar.  Aggravating factors included walking
especially long distances, footwear with straps or firm toe
box, plantarflexion, and at times light pressure, such as
bed linen touching the foot.  Relieving factors were
dorsiflexion and orthotics, which were prescribed by the
podiatrist.  No anti-inflammatories or cortisone injections
had been administered.  The patient’s general health was
reported as good, although the patient appeared a little
stressed due to workload at university.  She did not have
any hobbies or participate in any regular leisure activities.
Assessment and examination procedures revealed
decreased range of active plantarflexion of the left ankle
with associated pain.  All other active ranges of motion
were full and pain-free.  Passive ROM at the left ankle also
revealed decreased plantarflexion with provocation of the
patient’s familiar pain.  The patient had a positive Mulder’s
sign or Mulder’s click which also reproduced the patient’s
familiar pain.  Palpation in the third interspace revealed
exquisite tenderness with pins and needles radiating
proximally along dorsum of left foot.  The patient was
asked to plantarflex her foot, the painful ROM, whilst the
digital fascial tension test (DFTT) was performed.  DFTT
involves engaging the skin and underlying tissue where
the pain is experienced, and with a draw/drag effect pull
the local tissue away from the painful site.  Dragging the
skin inferiorly relieved the patients’ pain.  With the patients’
foot still plantarflexed, Fixomull â was placed on the skin
with overlying rigid Leuko sportstape â.  With one end of
the tape adhered to the painful site, the tape was applied in
the direction predetermined by the DFTT, inferiorly,
using a gathering technique to take up the slack in the skin
and underlying tissue.  This process was repeated three
times.  The tape was anchored both proximally and distally.
All active ROM were re-tested, and it was found that all
ROM were pain-free, including plantarflexion.  The patient
was advised to perform plantarflexion exercises, and to
keep the tape dry at all times.
Two days later the patient returned for re-taping.  The
patient commented, that she had been pain-free since the
initial taping session, however she had been experiencing
“shin-splint” type pain around the mid-shaft of the tibia
over tibialis anterior.  The neuroma was re-taped as
previous, as well as a second area of taping over the tibialis
anterior.  The DFTT was performed over tibialis anterior,
and the pain free direction was found to be on a diagonal,
inferomedial.  Upon taping these two consecutive areas,
the patient was again, pain-free.
The patient presented for re-taping every second day for
a period of two weeks.  Each taping session required
reassessment for pain-free ROM.  The tape was removed
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on every third taping session to allow the patient to wash
her foot.  The skin was properly cleansed to remove all
glue from previous taping.  On the third taping session the
patient had relief from the majority of her pain, with only
slight pain felt when wearing other footwear and after
gardening all day.  On the final taping session, the patient
reported her pain, according to FFI, as 0%.
INTERPRETATION OF CLINICAL OUTCOME
MEASURES
The patient reported that the clinical measures used were
easy to understand and complete.  Measures were
administered pre and post-treatment.  The patients’ FFI
scores pre-treatment for pain were 46%, for disability
18%, and for activity limitation 9% (see table 1).
At the initial consultation the patient reported her pain as
5%, however the patient reported her worst pain, according
to the FFI as 79%.  All that can be deduced from these
scores is that at the initial consultation, she was only
experiencing mild pain due to previous treatment from the
podiatrist, and by the second week of taping, the patient
experienced no pain.
On closer examination of the Pain Subscale, the main
improvements were walking barefoot, severity of pain at
its worst and throughout the day (Table 2).
From the above table, one is able to note the disability
parameters, which improved the most, were standing
tiptoe, walking outside and for considerable distance, as
well as descending stairs.  The patient also showed notable
improvements in her daily activities (Table 4).
DISCUSSION
Clinically, Morton’s neuroma is of great interest because
of the high incidence of disabling pain in patients who are
young, and often, professional athletes.  Much research
has been conducted in the area of Morton’s neuroma, and
its many varied treatment modalities.  It is the view of
many that conservative treatment should be exhausted
prior to any surgical intervention.  However, others
advocate surgery if conservative measures fail to
significantly reduce the patient’s pain and disability12,15,52,53.
Surgical intervention has involved surgical excision of the
neuroma via a plantar or dorsal approach and division of
the transverse intermetatarsal ligament.  The success of
surgery is varied with some authors stipulating 80% or
better success rate, whilst others comment that the patient
is fortunate to receive 75% relief from their symptoms,
with the average relief between 50-60%.  Scarring during
the healing process frequently interferes with the functions
of support, movement, and lubrication.  Soft tissue changes,
which also occur, lead to persistent symptoms long after
healing of the acute tissue injury46.
The patient was pain-free after the third taping session and
remained so, for the remainder of the treatment period.
The reduction in pain and improved ROM, enabled the
patient to participate in daily activities pain free, and for
the first time in several years, she was able to wear a
variety of footwear.  There was marked improvement in
the patient’s diurnal pain pattern, with pain in the morning
at the initial consultation rated 78%, whilst pain at the end
of the day rated 79%.  At the final consultation the
patient’s pain in the morning and at the end of the day rated
0% on the FFI.  The patient was also able to walk barefoot
without considerable pain, as at the final consultation the
pain rated 1%, as opposed to 43% at initial consultation.
There was also a notable improvement on the disability
subscale, with the patient indicating no difficulty walking
outside (Pre: 24%; Post: 0%), descending stairs (Pre:26%;
Post: 1%) or walking long distances (Pre: 30%; Post: 0%)
and minimal difficulty standing tip toe (Pre: 50%, Post:
8%).  The reason for these improvements is not well
understood, but it is a known fact that once the acute
trauma has resolved, there is residual scarring of the
 Pre-treatment  Post-treatment 
Pain   46%  0% 
Disability 18% 1% 
Activity limitation  9%  0% 
  Table 1:  Patient’s FFI scores
Table 2:  Pain Subscale
 Pre-treatment  Post-treatment 
Climbing stairs  10%  0% 
Walking around house  11%  0% 
Walking outside  24%  0% 
Descending stairs  26%  1% 
Standing tiptoe  50%  8% 
Walking 4 blocks  30%  0% 
Rising from chair  1%  0% 
Stepping up a curb  10%  0% 
Walking fast  16%  0% 
  Table 3:  Disability Subscale
 Pre-treatment  Post-treatment 
Staying indoors  2%  0% 
Staying in bed  1%  0% 
Limited daily activities  40%  0% 
Assistive devices indoors  0%  0% 
Assistive devices outdoors  0%  0% 
  Table 4:  Activity Limitation Subscale
 Pre-treatment  Post-treatment 
Walking barefoot  44%  1% 
Standing barefoot  6%  0% 
Pain at its worst  79%  0% 
Beginning of day  78%  0% 
End of day  79%  0% 
Walking with orthotics  5%  0% 
Walking without orthotics  51%  1% 
Walking with shoes on  27%  1% 
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surrounding tissues which leads to restricted motion and
fascial tension.  It is plausible that the load applied by the
tape stretched the scar tissue surrounding the nerve,
alleviating compression on the nerve, and thus resulting in
pain free movement.  Fascia has the capacity to change
when subjected to stress, and as such, when a load is
applied to this viscoelastic tissue, over a prolonged period
of time, the tissue will progressively deform until a new
resting length is achieved57-61.  Tillman and Herling54 also
showed that by gently stretching scar tissue, collagen
fibers are laid down parallel to the lines of stress, thus
changing the shape, strength and pliability of the connective
tissue55.  This was supported by Kottke, Pauley and Ptak56
who stipulated when there is little motion at a particular
area of the body, collagen is laid down as a dense network,
however if there is considerable motion, the connective
tissue will be remodeled so that it is loose and extensible.
It was also noted that when a load is applied to fascia,
connective tissue deformation increases with fluid loss.
Thus as the fluid volume in the connective tissue decreases,
the collagen configuration becomes floppy and more
elastic, therefore allowing reorganisation of the fibers
along the lines of stress57,58,60.
At six weeks follow-up, the patient noted minimal
discomfort, which was dependent on the amount of
physical activity she performed during the day.  While
rapid recovery is the immediate aim of any therapeutic
modality, it would be beneficial to assess the possible long-
term benefits of FFTä.  It is also imperative that future
studies of Morton’s neuroma utilise imaging modalities,
specifically MRI, to visualise the size of the neuroma pre
and post-treatment, to eliminate the possibility of placebo.
CONCLUSION
Morton’s neuroma is a painfully debilitating condition,
which often presents to Podiatrists.  Conservative therapy
is an essential component of the treatment of Morton’s
neuroma, as most patients can be treated non-operatively,
and only a few that don’t respond to these measures,
undergo surgical intervention.  At present there is little
research to explore the potential benefits of FFT ä to
alleviate pain and disability in patients suffering from
Morton’s neuroma.  This study does suggest that FFT ä has
beneficial effects, however a larger random controlled
study needs to be conducted, examining both long-term
and short-term effects of FFT ä.
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